Drugs give FTSE a lift

clock

The FTSE 100 index has lost 28.6 points, or 0.5%, to 5,856 points this morning, led by AstraZeneca.

Drug giant AstraZeneca has slipped back 1.04% to £32.30 after ING Financial changed its “buy” recommendation to “hold” as it awaits key developments over the next few months. William Morrison has fallen 0.62% to 200.5p after HSBC rated it as "overweight" with a price target of 240p. Sainsbury has been started with an 'underweight' recommendation and has fallen 0.22% to 334.25p. In Japan, the Nikkei 225 Stock Average added 66.88 points, or 0.4%, to 15,638.5 points as a US manufacturing report fuelled speculation the Federal Reserve might refrain from raising interest rates. Sony ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Rathbones looks for growth after year of internal focus during Investec merger

Rathbones looks for growth after year of internal focus during Investec merger

Growth in funds under management and administration to £115.6bn

Eve Maddock-Jones
clock 15 January 2026 • 3 min read
Brooks Macdonald returns to positive flows in Q2

Brooks Macdonald returns to positive flows in Q2

Funds under management/advice now top £20bn

Jenna Brown
clock 15 January 2026 • 2 min read
PA Awards 2026: Multi-asset shortlists revealed

PA Awards 2026: Multi-asset shortlists revealed

Championing excellence

Professional Adviser
clock 14 January 2026 • 2 min read